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Conclusion:
The coexistence of decreased frontal EEG alpha oscillation power at
0.6 to 0.9 % of Isoflurane and burst suppression at low volatile
anesthetic concentration might be a specific measure of brain ageing
induced by ongoing illnesses. (3) It depicts overall patient frailty which
presents clinically as increased sensitivity to anesthetics. (4)
Introduction: 
An individual’s frontal EEG signature during anesthesia usually remains
stable between surgeries with a given anesthetic agent, with spectral
power in the alpha range only decreasing slowly with age. (1)
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Methods: 
Frontal EEG was recorded from a 68 year old patient during three
cardiac surgeries (1st procedure for coronary artery bypass grafting, 2nd
for type A aortic dissection, 3rd for endoaortic graft infection) within a
7 month period, as part of the EPOCAS study (NCT02976584). During
this time course the patients condition declined with noticeable
general weakness, especially during aortic graft infection with
accompanying sepsis.
Mean end-tidal Isoflurane concentration (%) and mean oscillatory
alpha power (dB) were calculated for normothermic artifact free time
periods. Furthermore, the end-tidal Isoflurane concentration at which
the first 0.75 second isoelectric period of burst suppression in the EEG
was observed was determined to evaluate the sensitivity of the brain
to the administered anesthetic. (2) The amount of opioid and
benzodiazepines was recorded.
In Matlab® (R2016a) mean power spectra (Figure 1) were calculated
from two-second (non-overlapping) artefact and burst-suppression
free sections of pre and post bypass frontal EEG using the Fast Fourier
Transform. Oscillatory alpha power was calculated as the power
additional to the underlying broadband noise at the peak frequency
within an extended alpha range (7 to 17 Hz).
Figure 1: Mean power spectra calculated from
artefact and burst suppression free sections of pre
and post bypass frontal EEG. Oscillatory alpha
power was calculated as the power additional to
the underlying broadband noise at the peak
frequency within an extended alpha range (7 to 17
Hz).
During the third
procedure the patient had
low volatile anesthetic
concentrations (0.6 %
Isoflurane), with his EEG
not showing an alpha
oscillation, but rather
periods of burst-
suppression. The percent
of Isoflurane at which the
first 0.75 second
isoelectric period of burst
suppression in the EEG
was observed decreased
from 1.1 % during the first
intervention, to 0.8 %
during the second, and
then decreased further to
0.5 % during the final
case. No change in delta
power was observed over
the operations. Total
doses of Sufentanil and
Midazolam were similar.
Results: 
Spectral analyses showed a rapid decrease in alpha power (1st surgery:
2.1 dB at 0.95 % Isoflurane, 2nd: 1.75 dB at 0.61 %, 3rd: 0.35 dB at 0.59
%) over the course of 7 months, which was clinically associated with
increased frailty, see Figure 1.
